Renalytix Ai (Reg S) (RENX)

Sector:

Health Care

Index:

FTSE AIM 100

585.00p
   
  • Change Today:
      5.00p
  • 52 Week High: 625.00
  • 52 Week Low: 173.50
  • Currency: UK Pounds
  • Shares Issued: 72.03m
  • Volume: 437
  • Market Cap: £421.37m
  • RiskGrade: 282

RENX Overview

RenalytixAI is a developer of artificial intelligence (AI) enabled clinical decision support solutions for kidney disease, one of the most common and costly chronic medical conditions globally. RenalytixAI’s solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care and patient stratification for drug clinical trials.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 19.4  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

RENX Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-18 n/a (0.42) (1.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-19 n/a (6.52) (15.00)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

RENX Company Announcements

KidneyIntelX in Multi-Center Study 03-Aug-2020 07:00 RNS
Total Voting Rights 31-Jul-2020 16:31 RNS
Over allotment option exercise 27-Jul-2020 07:00 RNS

Latest RENX Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

RENX Market Data

Currency UK Pounds
Share Price 585.00p
Change Today 5.00p
% Change 0.86 %
52 Week High 625.00
52 Week Low 173.50
Volume 437
Shares Issued 72.03m
Market Cap £421.37m
RiskGrade 282

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
42.06% below the market average42.06% below the market average42.06% below the market average42.06% below the market average42.06% below the market average
21.05% below the sector average21.05% below the sector average21.05% below the sector average21.05% below the sector average21.05% below the sector average
Price Trend
82.86% above the market average82.86% above the market average82.86% above the market average82.86% above the market average82.86% above the market average
55.00% above the sector average55.00% above the sector average55.00% above the sector average55.00% above the sector average55.00% above the sector average
Income Not Available
Growth Not Available

RENX Dividends

No dividends found

Trades for 04-Aug-2020

Time Volume / Share Price
09:20 339 @ 588.00p
08:01 98 @ 588.00p

RENX Key Personnel

CEO James Renwick McCullough
CFO James Sterling
COO Sally Bowden

Top of Page